EL7.AI
Mergers & AcquisitionsMedium•17 November 2026•
1 min read

Rythm Pharmaceuticals Shares Rise on Reported Eli Lilly Buyout Offer

Lilly and Rhythm Pharmaceuticals display plaques with two vials, a folder and a pen, backed by illustrative green bars.

Key Facts

1Rythm Pharmaceuticals shares gained following reports that Eli Lilly made a $150 per share buyout offer.
2The alleged acquisition offer includes a Contingent Value Right (CVR) in addition to the cash price.

Rythm Pharmaceuticals shares gained following reports that Eli Lilly made a $150 per share buyout offer. Seeking Alpha reported that the alleged acquisition proposal includes a Contingent Value Right (CVR) in addition to the cash price.

LLY was trading at $1415.57 on November 17, 2026, reaching a session high of $1432.27. The reported offer signals Eli Lilly's continued expansion strategy within the pharmaceutical sector through potential multi-billion dollar acquisitions.

Open on chart